A Study to Learn About Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India
Conditions: Transthyretin Amyloid Cardiomyopathy Interventions: Drug: Tafamidis Sponsors: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Cardiomyopathy | Heart | India Health | Learning | Pfizer | Research | Study | Universities & Medical Training